Ligand Pharmaceuticals Inc(LGND)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
LGND is scheduled to report on Oct 29, 2026, before the market opens. Analysts expect EPS of $2.41.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±7.0%).
Did the stock rise after good news?
The next-day move after each of its last 10 EPS beats and 1 misses.
In plain words: it beat expectations 10 times, but the stock still fell 3 of those 10 times.
- Aug '26Beat▼ -0.8%
- May '26Missed▼ -9.6%
- Feb '26Beat▲ +2.5%
- Nov '25Beat▲ +9.4%
- Aug '25Beat▲ +2.8%
- May '25Beat▼ -2.9%
- Nov '24Beat▲ +11.1%
- Aug '24Beat▼ -5.8%
- May '24Beat▲ +7.2%
- Feb '24Beat▲ +19.9%
- Nov '23Beat▲ +4.6%
Clear beats and misses with a known reaction only. What counts as a beat
Why did LGND fall after beating earnings?
3 of LGND's last 11 reactions went against the EPS result. What stands out in each:
LGND beat EPS estimates in 10 quarters, and the stock still closed lower the next day 3 times. In 3 of the 3 where we have price data, the stock had already run up before the report.
- Aug 6, 2026EPS beat +21.5%stock -0.8% next day
- It had risen 5.1% in the final week before the report, so good news may already have been priced in.
- It opened 1.2% higher, but sellers took over and it closed -0.8%.
- May 8, 2025EPS beat +9.9%stock -2.9% next day
- It had risen 9.3% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 1.2% higher, but sellers took over and it closed -2.9%.
- Aug 6, 2024EPS beat +32.1%stock -5.8% next day
- It had risen 8.0% in the 20 trading sessions before the report, so good news may already have been priced in.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was LGND's earnings move already priced in?
LGND's move in the month before each of its last 11 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 11 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does LGND hold its opening gap after earnings?
LGND's opening move after each report and where it closed that day.
In 9 reports LGND opened at least 1% away from the previous close. It gave back half or more of that gap by the close 3 of 9 times (33%), and fully reversed 3 times. Gaps up faded 2 of 7; gaps down recovered 1 of 2.
- Aug 6, 2026ReversedOpened +1.2%, closed -0.8%
- May 7, 2026HeldOpened -11.8%, closed -9.6%
- Nov 6, 2025HeldOpened +3.0%, closed +9.4%
- Aug 7, 2025HeldOpened +1.7%, closed +2.8%
- May 8, 2025ReversedOpened +1.2%, closed -2.9%
- Nov 7, 2024HeldOpened +1.2%, closed +11.1%
- May 8, 2024ReversedOpened -1.4%, closed +7.2%
- Feb 27, 2024HeldOpened +14.5%, closed +19.9%
LGND earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Before open | $1.95 | $2.37 | +21.5% | -0.80% | -2.27% |
| May 7, 2026 | Before open | $1.80 | $1.63 | -9.4% | -9.55% | -5.19% |
| Feb 26, 2026 | Before open | $1.50 | $2.02 | +34.7% | +2.50% | +5.83% |
| Nov 6, 2025 | Before open | $1.93 | $3.09 | +60.1% | +9.37% | +9.93% |
| Aug 7, 2025 | Before open | $1.42 | $1.60 | +12.7% | +2.75% | +3.24% |
| May 8, 2025 | Before open | $1.21 | $1.33 | +9.9% | -2.94% | +0.72% |
| Feb 27, 2025 | Before open | $1.19 | $1.27 | +6.7% | — | — |
| Nov 7, 2024 | Before open | $1.35 | $1.84 | +36.3% | +11.12% | +5.62% |
| Aug 6, 2024 | After close | $1.06 | $1.40 | +32.1% | -5.78% | +1.13% |
| May 8, 2024 | After close | $0.83 | $1.20 | +44.6% | +7.17% | +4.62% |
| Feb 27, 2024 | Before open | $0.66 | $1.38 | +109.1% | +19.86% | +6.62% |
| Nov 8, 2023 | After close | $0.62 | $1.02 | +64.5% | +4.61% | +5.63% |
Consensus for the next report: EPS $2.41, revenue $78.78M.
LGND Earnings FAQ
Answers computed from Ligand Pharmaceuticals Inc's reported history
LGND is scheduled to report on Oct 29, 2026, before the market opens. Analysts expect EPS of $2.41.
Over the last 12 quarters with a usable EPS surprise, LGND beat the consensus estimate 11 times (92%), missed 1 and landed in line 0.
Across its last 11 quarters with a measured reaction, LGND moved an average of ±7.0% in the first session after reporting. It closed higher 64% of the time; the largest gain was 19.9% and the largest drop -9.6%.
LGND fell in the first session after 3 of its last 10 EPS beats (30%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 3 of the 3 of those falls where price data is available, the stock had already risen before the report.
Across its last 11 quarters with price data, LGND moved an average of +3.8% in the 20 trading sessions before reporting and was higher in 55% of them. After a run-up of 3% or more (6 quarters), it fell the next day 50% of the time, averaging +0.8%. This describes past reports; it is not a forecast.
In 9 reports LGND opened at least 1% away from the previous close. It gave back half or more of that gap by the close 3 of 9 times (33%), and fully reversed 3 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · LGND: 12 reported quarters, latest Aug 6, 2026. Information only, not investment advice.
Looking for more on LGND?
Price charts, forecast, fundamentals and risk pages for LGND are not on Tickzen yet. You can run a full stock analysis now.
Run the LGND Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun